Allosteric Modulation

Latest News for: allosteric modulation

Edit

Neumora Therapeutics Announces Initiation of Phase 1 Clinical Study of M4 Positive Allosteric Modulator NMRA-861

Nasdaq Globe Newswire 09 Jul 2025

NMRA-861 has potential best-in-class pharmacology, which may enable a more favorable therapeutic profile ... .

Edit

Structure-based discovery of positive allosteric modulators of the A1 adenosine receptor

PNAS 07 Jul 2025

SignificanceOur research marks a pivotal advance in allosteric drug ...

Edit

Addex Partner Indivior Advances GABAB Positive Allosteric Modulator Program Successfully Through IND Enabling Studies

Nasdaq Globe Newswire 12 May 2025

Ad Hoc Announcement Pursuant to Art. 53 LR ... .

Edit

Addex Partner Indivior Advances GABAB Positive Allosteric Modulator Program Successfully Through IND Enabling Studies (Form 6-K) (Addex Therapeutics Ltd)

Public Technologies 12 May 2025

... allosteric modulators for neurological disorders, announced today partner Indivior has successfully advanced its GABAB positive allosteric modulator (PAM) program through IND enabling studies.

Article Search

tools

You can search using any combination of the items listed below.

Language:

Sort:

Indexed:

Search:

Duplicates:

Podcasts:

Latest News for: allosteric modulation

Neumora Therapeutics Announces Initiation of Phase 1 Clinical Study of M4 Positive Allosteric Modulator NMRA-861

Structure-based discovery of positive allosteric modulators of the A1 adenosine receptor

Addex Partner Indivior Advances GABAB Positive Allosteric Modulator Program Successfully Through IND Enabling Studies

Addex Partner Indivior Advances GABAB Positive Allosteric Modulator Program Successfully Through IND Enabling Studies (Form 6-K) (Addex Therapeutics Ltd)

Article Search

EXPLORE WN.com